News
8th Annual eCOA Forum Hosted by Signant Health to Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology
Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technology. Held at Philadelphia’s Franklin Institute on December 10-11,...
News
CPhI Annual Report predicts Europe to surpass the USA in biologic manufacturing capacity by 2023
CPhI Worldwide – the world’s largest pharma event, taking place in Frankfurt, Germany (5-7 November, 2019) – releases the second part of its annual report focussed on biologicals.
Fittingly, in 2019 BioProduction – which features five concurrent streams of content...
News
Catalent To Debate Logistics Of Delivery And Transportation Of Cell And Gene Therapies At HPCLC
Catalent, a global leader in clinical supply services, announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “ Cell and Gene Therapy Logistics ” at the upcoming...
Clinical Trials
WFS awarded GDP certifications for Johannesburg and Cape Town pharma facilities
Worldwide Flight Services (WFS) has become the first air cargo handling company in South Africa to be awarded Good Distribution Practice (GDP) certifications for its temperature controlled pharma facilities, aligned to ISO9001:2015, in Johannesburg and Cape Town.
This latest WFS...
Clinical Trials
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced that the Phase 1a solid tumor trial exploring the safety and tolerability of AVID200, a first-in-class TGF-beta 1 & 3 selective inhibitor, administered as...
Clinical Trials
MabThera meets primary endpoint in PEMPHIX trial in pemphigus vulgaris
Roche said that the phase 3 PEMPHIX trial of MabThera (rituximab) in moderate to severe pemphigus vulgaris (PV) met its primary endpoint at Week 52.
The PEMPHIX trial also showed that MabThera was superior to mycophenolate mofetil (MMF) in the...
Clinical Trials
WellVia partners with Health Gorilla to power clinical record retrieval and lab ordering
Health Gorilla, a leader in clinical data APIs, and WellVia, a premier telehealth company, announced a partnership that enables new data exchange capabilities within the WellVia telehealth platform. WellVia will utilize Health Gorilla's FHIR APIs to equip healthcare providers...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















